Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling.

Locatelli F, Kabbara N, Ruggeri A, Ghavamzadeh A, Roberts I, Li CK, Bernaudin F, Vermylen C, Dalle JH, Stein J, Wynn R, Cordonnier C, Pinto F, Angelucci E, Socié G, Gluckman E, Walters MC, Rocha V; Eurocord and European Blood and Marrow Transplantation (EBMT) group.

Blood. 2013 Aug 8;122(6):1072-8. doi: 10.1182/blood-2013-03-489112. Epub 2013 May 21.

2.

Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies.

Soni S, Boulad F, Cowan MJ, Scaradavou A, Dahake J, Edwards S, Walters MC.

Pediatr Blood Cancer. 2014 Sep;61(9):1690-4. doi: 10.1002/pbc.25085. Epub 2014 May 7.

PMID:
24803091
3.

Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.

Zakerinia M, Khojasteh HN, Ramzi M, Haghshenas M.

Transplant Proc. 2005 Dec;37(10):4477-81.

PMID:
16387149
4.

Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease.

Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S, Brichard B, Li X, Nagler A, Giorgiani G, Haut PR, Brochstein JA, Nugent DJ, Blatt J, Woodard P, Kurtzberg J, Rubin CM, Miniero R, Lutz P, Raja T, Roberts I, Will AM, Yaniv I, Vermylen C, Tannoia N, Garnier F, Ionescu I, Walters MC, Lubin BH, Gluckman E; Eurocord Transplant Group.

Blood. 2003 Mar 15;101(6):2137-43. Epub 2002 Nov 7.

5.

PBSCT is associated with poorer survival and increased chronic GvHD than BMT in Japanese paediatric patients with acute leukaemia and an HLA-matched sibling donor.

Shinzato A, Tabuchi K, Atsuta Y, Inoue M, Inagaki J, Yabe H, Koh K, Kato K, Ohta H, Kigasawa H, Kitoh T, Ogawa A, Takahashi Y, Sasahara Y, Kato S, Adachi S.

Pediatr Blood Cancer. 2013 Sep;60(9):1513-9. doi: 10.1002/pbc.24524. Epub 2013 Mar 19.

PMID:
23512888
6.

Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.

Schönberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kögler G, Enzmann J, Wernet P, Göbel U, Dilloo D.

Klin Padiatr. 2004 Nov-Dec;216(6):356-63.

PMID:
15565551
8.

Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.

J Clin Oncol. 2004 Feb 1;22(3):416-23. Epub 2003 Dec 22.

PMID:
14691124
9.

Long-term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: an analysis on behalf of Eurocord-EBMT.

Herr AL, Kabbara N, Bonfim CM, Teira P, Locatelli F, Tiedemann K, Lankester A, Jouet JP, Messina C, Bertrand Y, Díaz de Heredia C, Peters C, Chaves W, Nabhan SK, Ionescu I, Gluckman E, Rocha V.

Blood. 2010 Sep 16;116(11):1849-56. doi: 10.1182/blood-2010-02-271692. Epub 2010 Jun 10.

11.

Analysis of immune reconstitution in children undergoing cord blood transplantation.

Moretta A, Maccario R, Fagioli F, Giraldi E, Busca A, Montagna D, Miniero R, Comoli P, Giorgiani G, Zecca M, Pagani S, Locatelli F.

Exp Hematol. 2001 Mar;29(3):371-9.

PMID:
11274766
12.

Hemoglobin disorders: a look to the future.

Nathan DG.

Blood. 2013 Aug 8;122(6):859-60. doi: 10.1182/blood-2013-06-506154.

13.

Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.

Weisdorf DJ, Anasetti C, Antin JH, Kernan NA, Kollman C, Snyder D, Petersdorf E, Nelson G, McGlave P.

Blood. 2002 Mar 15;99(6):1971-7.

14.

Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants.

Gaziev D, Galimberti M, Lucarelli G, Polchi P, Giardini C, Angelucci E, Baronciani D, Sodani P, Erer B, Biagi MD, Andreani M, Agostinelli F, Donati M, Nesci S, Talevi N.

Bone Marrow Transplant. 2000 Apr;25(8):815-21.

15.

Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group.

Peters C, Shapiro EG, Anderson J, Henslee-Downey PJ, Klemperer MR, Cowan MJ, Saunders EF, deAlarcon PA, Twist C, Nachman JB, Hale GA, Harris RE, Rozans MK, Kurtzberg J, Grayson GH, Williams TE, Lenarsky C, Wagner JE, Krivit W.

Blood. 1998 Apr 1;91(7):2601-8.

16.

Comparable outcomes of HLA-matched unrelated and HLA-identical sibling donor bone marrow transplantation for childhood acute myeloid leukemia in first remission.

Lee DH, Kwon YJ, Lim J, Kim Y, Han K, Chung NG, Jeong DC, Cho B, Kim HK.

Pediatr Transplant. 2009 Mar;13(2):210-6. doi: 10.1111/j.1399-3046.2008.00997.x. Epub 2008 Jul 1.

PMID:
18627512
17.

Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.

Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.

Klin Padiatr. 2005 May-Jun;217(3):135-41.

PMID:
15858704
18.

Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia.

Elmaagacli AH, Basoglu S, Peceny R, Trenschel R, Ottinger H, Lollert A, Runde V, Grosse-Wilde H, Beelen DW, Schaefer UW.

Blood. 2002 Feb 15;99(4):1130-5.

19.

CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.

Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.

Biol Blood Marrow Transplant. 1997 Apr;3(1):11-7.

PMID:
9209736
20.

Use of partially mismatched related donors extends access to allogeneic marrow transplant.

Henslee-Downey PJ, Abhyankar SH, Parrish RS, Pati AR, Godder KT, Neglia WJ, Goon-Johnson KS, Geier SS, Lee CG, Gee AP.

Blood. 1997 May 15;89(10):3864-72.

Supplemental Content

Support Center